Global Portable Slit Lamp Market is Gaining Significant Traction with Introduction of SL-D4 LED Slit Lamp with LED Illumination by Topcon Medical Systems, Inc.

 

PORTABLE SLIT LAMP MARKET

The portable slit lamp is suitable for many different applications and can be used as either a fixed unit or as an adjustable device. The portable slit lamp is available with a single, double, or triple light source. Some applications require the use of a dedicated light source that is controlled by means of a rotary knob or foot pedal. These instruments may also include provision for direct current (DC) and/or an electrical adapter to connect the power source directly to the bulb. The portable slit camera can be used to examine eye defects in the early stages of development and screening, whereas the advanced classification examination can be done on a wide range of standard visual applications such as the BA 904. These instruments allow the visual inspector to determine if the eye disease or condition is progressive, specific, or similar to glaucoma.

Increasing incidence of cataracts and other eye disorders is expected to drive growth of the global portable slit lamp market during the forecast period. According to the American Academy of Ophthalmology, cataracts affect over 24.4 million U.S. citizens aged 40 years and above. According to the World Health Organization (WHO), cataracts are the major reason for worldwide blindness and around 65.2 million people are affected by cataracts. Portable slit lamp is mainly used to examine various eye diseases including cataracts. It is used to examine the posterior and anterior segments of the human eye. Thus, these factors are expected to drive growth of the global portable slit lamp market during the forecast period. Moreover, the geriatric population is expected to boost the global portable slit lamp market growth over the forecast period. According to the WHO, by 2050, around 2 billion people worldwide are expected to be aged 60 years and above.

However, irritation in the eye caused by a bright light in a portable slit lamp leading to temporary blindness in eye sensitive patients is expected to hinder the global portable slit lamp market growth over the forecast period. Among regions, North America is expected to witness significant growth in the global portable slit lamp market during the forecast period. This is owing to proactive initiatives by government authorities to improve visual health in the region. Furthermore, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to rising focus on R&D activities on upgrading portable slit lamps.

Key players operating in the global portable slit lamp market are Shin Nippon, ChongQing KangHua S & T Co., Ltd., Suzhou Kangjie Medical Inc., Kowa Optimed Inc., Keeler (Halma plc), Haag-Streit Holding, Carl Zeiss Meditec AG, OCULUS Optikgeräte GmbH, MEDELSIS Medical Electronic Systems A.S., and Topcon Medical Systems, Inc.

For instance, in December 2019, Topcon Medical Systems, Inc. introduced a new SL-D4 LED Slit Lamp with LED Illumination

Location: India

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more